Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DX3VDO
|
||||
| Drug Name |
(R)-4-(3,4-Difluoro-phenyl)-2-methyl-6-oxo-1,4,5,6-tetrahydro-pyridine-3-carboxylic acid {3-[4-cyano-4-(2,4-difluoro-phenyl)-piperidin-1-yl]-propyl}-amide
|
||||
| Synonyms |
CHEMBL295001
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C28H28F4N4O2
|
||||
| Canonical SMILES |
CC1=C([C@H](CC(=O)N1)c2ccc(F)c(F)c2)C(=O)NCCCN3CCC(CC3)(C#N)c4ccc(F)cc4F
|
||||
| InChI |
InChI=1S/C28H28F4N4O2/c1-17-26(20(15-25(37)35-17)18-3-6-22(30)24(32)13-18)27(38)34-9-2-10-36-11-7-28(16-33,8-12-36)21-5-4-19(29)14-23(21)31/h3-6,13-14,20H,2,7-12,15H2,1H3,(H,34,38)(H,35,37)/t20-/m1/s1
|
||||
| InChIKey |
RLMGUPUESXPDFJ-HXUWFJFHSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Alpha-1 adrenergic receptor | Target Info | [1587926] | ||
| Histamine H1 receptor | Target Info | [1587926] | |||
| PANTHER Pathway | Histamine H1 receptor mediated signaling pathway | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.